Which statement about Tuskegee Phase I (1932-1936) is accurate?

Get ready for your Bioethics Exam. Prepare with a comprehensive set of flashcards, multiple-choice questions, and expert explanations that enhance understanding. Achieve your certification with confidence!

Multiple Choice

Which statement about Tuskegee Phase I (1932-1936) is accurate?

Explanation:
The essential point is that Phase I was designed to document the natural history of syphilis by following untreated cases among Black men in Alabama. This observational aim meant that participants were not treated with penicillin as a standard therapy, so the statement about offering penicillin as standard treatment is incorrect. Informed consent was not fully met—participants were misled about the study’s purpose and what they were being treated for, and they did not receive complete information or genuine consent. The study also was not conducted with multinational pharmaceutical company involvement; it was a government-supported project in collaboration with the Tuskegee Institute. Understanding this phase helps explain why the study is a pivotal, but deeply troubling, example in research ethics, illustrating why contemporary standards demand informed consent, transparency, and access to proven effective treatment.

The essential point is that Phase I was designed to document the natural history of syphilis by following untreated cases among Black men in Alabama. This observational aim meant that participants were not treated with penicillin as a standard therapy, so the statement about offering penicillin as standard treatment is incorrect. Informed consent was not fully met—participants were misled about the study’s purpose and what they were being treated for, and they did not receive complete information or genuine consent. The study also was not conducted with multinational pharmaceutical company involvement; it was a government-supported project in collaboration with the Tuskegee Institute. Understanding this phase helps explain why the study is a pivotal, but deeply troubling, example in research ethics, illustrating why contemporary standards demand informed consent, transparency, and access to proven effective treatment.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy